Citation Impact
Citing Papers
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
2011 Standout
Food Intake during the Normal Activity Phase Prevents Obesity and Circadian Desynchrony in a Rat Model of Night Work
2010
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Attenuated GLP-1 secretion in obesity: cause or consequence?
1996
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer
2005 StandoutNobel
Molecular mechanisms underlying nutrient-stimulated incretin secretion
2010
Transcriptional architecture of the mammalian circadian clock
2016 Standout
Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum
2003
Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus
2000 Standout
Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits
2001
Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans
1999
Dynamic PER repression mechanisms in the Drosophila circadian clock: from on-DNA to off-DNA
2010 StandoutNobel
Microbial tryptophan catabolites in health and disease
2018 Standout
MC4R Agonists: Structural Overview on Antiobesity Therapeutics
2018 StandoutNobel
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
What do we know about the secretion and degradation of incretin hormones?
2005
Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane
2009 StandoutNobel
Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist1
2000
When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders
2011 StandoutNobel
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Gene Model 129 (Gm129) Encodes a Novel Transcriptional Repressor That Modulates Circadian Gene Expression
2014 StandoutNobel
Effect of Reducing Interns' Weekly Work Hours on Sleep and Attentional Failures
2004 Standout
The biology of incretin hormones
2006 Standout
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract
2011
Osteoporosis: now and the future
2011 Standout
Slow Wave Sleep Enhancement with Gaboxadol Reduces Daytime Sleepiness During Sleep Restriction
2008
The effects of shift work on body weight change − a systematic review of longitudinal studies
2011
Electrical activity‐triggered glucagon‐like peptide‐1 secretion from primary murine L‐cells
2011
Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
1996
Circadian Orchestration of the Hepatic Proteome
2006
Sleep and the metabolic syndrome
2006
Biology of Incretins: GLP-1 and GIP
2007 Standout
The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans
2000
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
2001
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
2005
Interneuron‐mediated inhibition synchronizes neuronal activity during slow oscillation
2012
Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation
2010
Neural regulation of glucagon-like peptide-1 secretion in pigs
2004
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
2005
Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus
1995 Standout
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
2002
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.
1996
The Physiology of Glucagon-like Peptide 1
2007 Standout
Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock
2011 StandoutNobel
A clockwork web: circadian timing in brain and periphery, in health and disease
2003
Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin
2003
Management of severe osteoporosis
2015
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Insulin, Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Insulin-Like Growth Factor I as Putative Mediators of the Hypolipidemic Effect of Oligofructose in Rats
1998
Glucagonlike peptide 1: A newly discovered gastrointestinal hormone
1994
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
2009 Standout
Internal desynchronization in a model of night-work by forced activity in rats
2008
Protein Kinase Cζ Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells
2006
Glucagon-Like Peptide-1 7-36 Amide and Peptide YY Have Additive Inhibitory Effect on Gastric Acid Secretion in Man
1997
The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-l, but not to glucose-dependent insulinotropic polypeptide, in the portal vein
1996
Coordination of circadian timing in mammals
2002 StandoutNature
Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide
1995
The major glucagon-like peptide-1 metabolite, GLP-1-(9–36)-amide, does not affect glucose or insulin levels in mice
2004
G-Protein-Coupled Receptors in Intestinal Chemosensation
2012
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects
2003
The Oscillating miRNA 959-964 Cluster Impacts Drosophila Feeding Time and Other Circadian Outputs
2012 StandoutNobel
Muscarinic Receptors Control Glucagon-Like Peptide 1 Secretion by Human Endocrine L Cells
2003
Gut microbiota in human metabolic health and disease
2020 Standout
Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum
2000
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility
2005
Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion
2003
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
Rapid Oscillations in Plasma Glucagon-Like Peptide-1 (GLP-1) in Humans: Cholinergic Control of GLP-1 Secretion via Muscarinic Receptors1
1997
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Chronobiology, endocrinology, and energy‐ and food‐reward homeostasis
2013
Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion*
1999
Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow
1998
Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1
1996
Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells
2002
Circadian Rhythms and Metabolic Syndrome
2010
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential
1999
About Sleep's Role in Memory
2013 Standout
A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage
2017
The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.
1997
A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line
2003
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
2003
Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans
2015
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues
2004 Standout
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion
2001
The Metabolic Syndrome
2008 Standout
The Glucagon-Like Peptides
1999
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice
2002
Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis
2019
The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
1998 Standout
Entrainment of the Circadian Clock in the Liver by Feeding
2001 StandoutScience
Inhibition of carbohydrate-mediated glucagon-like peptide-I (7–36)amide secretion by circulating non-esterified fatty acids
1999
Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
2002
Glucagon-Like Peptide-1, But Not Glucose-Dependent Insulinotropic Peptide, Regulates Fasting Glycemia and Nonenteral Glucose Clearance in Mice*
2000
Initiation of Increased Pancreatic Islet Growth in Young Normoglycemic Mice (Umea +/?)*
1999
Gut chemosensing mechanisms
2015
Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
1999
Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day
1996
Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
2002
Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
2005
Works of Steve Deacon being referenced
Efficacy of the selective extrasynaptic GABAA agonist, gaboxadol, in a model of transient insomnia: A randomized, controlled clinical trial
2007
Adapting to phase shifts, I. An experimental model for jet lag and shift work
1996
Glucagon-like peptide-1(7–36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns
1993
Altered postprandial hormone and metabolic responses in a simulated shift work environment
1998
Effect of Short-term Treatment With Gaboxadol on Sleep Maintenance and Initiation in Patients With Primary Insomnia
2007
Effects of the endogenous clock and sleep time on melatonin, insulin, glucose and lipid metabolism
1998
Postprandial hormone and metabolic responses in simulated shift work
1996
Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: The OCEAN study
2011
Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
2013
Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep
2009